» Articles » PMID: 24416359

Correcting the Cystic Fibrosis Disease Mutant, A455E CFTR

Overview
Journal PLoS One
Date 2014 Jan 14
PMID 24416359
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis is caused by more than 1000 mutations, the most common being the ΔF508 mutation. These mutations have been divided into five classes [1], with ΔF508 CFTR in class II. Here we have studied the class V mutation A455E. We report that the mature and immature bands of A455E are rapidly degraded primarily by proteasomes; the short protein half-life of this mutant therefore resembles that of ΔF508 CFTR. A455E could be rescued by treatment of the cells with proteasome inhibitors. Furthermore, co-transfection of A455E with the truncation mutant Δ264 CFTR also rescued the mature C band, indicating that A455E can be rescued by transcomplementation. We found that Δ264 CFTR bound to A455E, forming a bimolecular complex. Treatment with the compound correctors C3 and C4 also rescued A455E. These results are significant because they show that although ΔF508 belongs to a different class than A455E, it can be rescued by the same strategies, offering therapeutic promise to patients with Class V mutations.

Citing Articles

Cystic Fibrosis Human Organs-on-a-Chip.

Ogden H, Kim H, Wikenheiser-Brokamp K, Naren A, Mun K Micromachines (Basel). 2021; 12(7).

PMID: 34202364 PMC: 8305167. DOI: 10.3390/mi12070747.


Phenotyping of Rare Mutations Reveals Distinct Trafficking and Functional Defects.

Ensinck M, De Keersmaecker L, Heylen L, Ramalho A, Gijsbers R, Farre R Cells. 2020; 9(3).

PMID: 32204475 PMC: 7140603. DOI: 10.3390/cells9030754.


Steric Inhibition of 5' UTR Regulatory Elements Results in Upregulation of Human CFTR.

Sasaki S, Sun R, Bui H, Crosby J, Monia B, Guo S Mol Ther. 2019; 27(10):1749-1757.

PMID: 31351782 PMC: 6822282. DOI: 10.1016/j.ymthe.2019.06.016.


Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Khan M, Ali Z, Sweezey N, Grasemann H, Palaniyar N Genes (Basel). 2019; 10(3).

PMID: 30813645 PMC: 6471578. DOI: 10.3390/genes10030183.


Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome.

Liu Q, Sabirzhanova I, Yanda M, Bergbower E, Boinot C, Guggino W J Cyst Fibros. 2018; 17(5):582-594.

PMID: 29936070 PMC: 6435267. DOI: 10.1016/j.jcf.2018.05.016.


References
1.
Boucher R . Current status of CF gene therapy. Trends Genet. 1996; 12(3):81-4. DOI: 10.1016/0168-9525(96)81410-7. View

2.
Pedemonte N, Lukacs G, Du K, Caci E, Zegarra-Moran O, Galietta L . Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest. 2005; 115(9):2564-71. PMC: 1190372. DOI: 10.1172/JCI24898. View

3.
Fulmer S, Schwiebert E, Morales M, Guggino W, Cutting G . Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc Natl Acad Sci U S A. 1995; 92(15):6832-6. PMC: 41423. DOI: 10.1073/pnas.92.15.6832. View

4.
Van Goor F, Hadida S, Grootenhuis P, Burton B, Cao D, Neuberger T . Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A. 2009; 106(44):18825-30. PMC: 2773991. DOI: 10.1073/pnas.0904709106. View

5.
Cheng S, Gregory R, Marshall J, Paul S, Souza D, White G . Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990; 63(4):827-34. DOI: 10.1016/0092-8674(90)90148-8. View